Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
07/27/2000 | WO2000027875A3 Activity dependent neurotrophic factor iii (adnf iii) |
07/27/2000 | WO2000023618B1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
07/27/2000 | WO2000023588A3 G-protein coupled receptors |
07/27/2000 | WO2000023096A3 Combination therapy with vip antagonist |
07/27/2000 | WO2000023094A3 Methods of inhibiting platelet activation and recruitment |
07/27/2000 | WO2000022001A8 A potassium channel of the erg family |
07/27/2000 | WO2000021553A3 Method of regulating smn gene expression |
07/27/2000 | WO2000021550A3 Methods and compositions for treating neurodegenerative diseases |
07/27/2000 | WO2000018915A3 Membrane-associated organizational proteins |
07/27/2000 | WO2000018232A8 Method of treatment of cardiovascular injuries |
07/27/2000 | WO2000017375A3 Method to treat haemophilia by in vivo gene therapy with retroviral vectors |
07/27/2000 | WO2000017328A3 Fibrils |
07/27/2000 | WO2000017225A3 A small protein that interacts with a ribonucleotide reductase subunit and uses thereof |
07/27/2000 | WO2000014254A3 Component of bromelain |
07/27/2000 | WO2000012683A9 Stem cells bearing an fgf receptor on the cell surface |
07/27/2000 | WO2000011171A3 Human rna-associated proteins |
07/27/2000 | WO2000005253A9 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
07/27/2000 | WO2000004157A3 Cloning and characterisation of novel mammalian peptidases |
07/27/2000 | WO2000003743A9 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
07/27/2000 | WO1999045116A9 Human homolog of a nuclear migration gene and its use |
07/27/2000 | WO1999036431A9 Compounds with growth hormone releasing properties |
07/27/2000 | WO1999009149A9 Three-dimensional polymer matrices |
07/27/2000 | DE19902550A1 A novel aspartate protease, coding sequence, inhibitors and antibodies, useful for treatment and diagnosis of Alzheimer's disease |
07/27/2000 | CA2627837A1 Pharmaceutical compositions for alleviating discomfort |
07/27/2000 | CA2366844A1 Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents |
07/27/2000 | CA2361276A1 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
07/27/2000 | CA2361272A1 33 human secreted proteins |
07/27/2000 | CA2361138A1 Alpha-conotoxin peptides |
07/27/2000 | CA2361123A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
07/27/2000 | CA2361122A1 Methods and devices for delivery of agents to breast milk ducts |
07/27/2000 | CA2360803A1 Lipophilic quenching of viral inactivating agents |
07/27/2000 | CA2360609A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
07/27/2000 | CA2360585A1 Protease |
07/27/2000 | CA2360065A1 Lipoprotein complexes and compositions containing them |
07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
07/27/2000 | CA2360058A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
07/27/2000 | CA2359681A1 Method of treating chronic cardiac disease |
07/27/2000 | CA2359633A1 Homing pro-apoptotic conjugates and methods of using same |
07/27/2000 | CA2359561A1 Proteasome inhibitors |
07/27/2000 | CA2359482A1 Organoprotective solutions |
07/27/2000 | CA2359145A1 Exocytosis pathway proteins and methods of use |
07/27/2000 | CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | CA2359096A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
07/27/2000 | CA2358971A1 Identifying, monitoring, and treating women for breast precancer or cancer |
07/27/2000 | CA2358963A1 Cancer-associated proteins |
07/27/2000 | CA2358914A1 Polypeptides derived from jnk3 |
07/27/2000 | CA2358873A1 Human polypeptide having multiple epidermal growth factor (egf) -like domains, zntr2 |
07/27/2000 | CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery |
07/27/2000 | CA2358093A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | CA2356681A1 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
07/27/2000 | CA2356642A1 Improved phytases |
07/26/2000 | EP1022338A2 Viral vaccines |
07/26/2000 | EP1022336A1 POLYPEPTIDE, cDNA ENCODING THE SAME, AND USE OF THEM |
07/26/2000 | EP1022333A1 Human tumor suppressor gene |
07/26/2000 | EP1022286A1 POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH |
07/26/2000 | EP1022268A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
07/26/2000 | EP1022027A1 Tumor necrosis factor antagonists and their use in endometriosis |
07/26/2000 | EP1021564A1 Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability |
07/26/2000 | EP1021555A1 STABILIZATION OF $i(HELICOBACTER) UREASE |
07/26/2000 | EP1021553A2 Eukaryotic gene expression cassette and uses thereof |
07/26/2000 | EP1021549A2 SENSE mRNA THERAPY |
07/26/2000 | EP1021546A1 Neutral sphingomyelinase |
07/26/2000 | EP1021544A2 Chimeric vaccine against tick-borne encephalitis virus |
07/26/2000 | EP1021543A1 Mutants of yeast cdc24p, defective in binding of the g-protein beta subunit |
07/26/2000 | EP1021542A1 Apo-3 ligand |
07/26/2000 | EP1021541A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
07/26/2000 | EP1021540A1 Human progesterone receptor complex p23-like protein |
07/26/2000 | EP1021539A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
07/26/2000 | EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor |
07/26/2000 | EP1021535A2 Human cancer antigen ny eso-1/cag-3 and gene encoding same |
07/26/2000 | EP1021534A1 Hepatitis c receptor protein cd81 |
07/26/2000 | EP1021533A1 Nucleic acids coding for proteins capable of interacting with presenilins |
07/26/2000 | EP1021464A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
07/26/2000 | EP1021461A1 Use of neuronal and lymphocytic potassium canal inhibitors for treating neurological diseases of immune origin |
07/26/2000 | EP1021458A1 Helicobacter polypeptides and corresponding polynucleotide molecules |
07/26/2000 | EP1021424A1 Thiadiazole amide mmp inhibitors |
07/26/2000 | EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION |
07/26/2000 | EP1021209A1 Inactivation of viruses by incubation with caprylate |
07/26/2000 | EP1021202A1 Immunogenic peptides from the hpv e7 protein |
07/26/2000 | EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
07/26/2000 | EP1021200A1 Methods and compositions for treating rheumatoid arthritis |
07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
07/26/2000 | EP1021197A1 Implants comprising combinations of allogeneic cells for use in cancer treatment |
07/26/2000 | EP1021190A1 Novel amide derivatives |
07/26/2000 | EP1021169A1 Active agent transport systems |
07/26/2000 | EP1021167A1 High and low load formulations of igf-i in multivesicular liposomes |
07/26/2000 | EP1021134A1 Use of hemoglobin to prevent sepsis or treat systemic inflammatory response syndrome |
07/26/2000 | EP0832134B1 Anti-allergy bispecific molecules |
07/26/2000 | EP0821697B1 Method for preparing streptogramines |
07/26/2000 | EP0769054B1 Immunomodulators |
07/26/2000 | EP0762890B1 Treatment of diabetes |
07/26/2000 | EP0759775B1 Ifn-beta liquid formulations |
07/26/2000 | EP0650374B1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant |
07/26/2000 | EP0643583B1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |
07/26/2000 | EP0629293B1 Assay for adrenal autoantibodies |
07/26/2000 | EP0576522B1 A single dose vaccination system |
07/26/2000 | CN1261403A Surface exposed proteins from chlamydia pneumoniae |